Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 29, 2014 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners to Present at the Jefferies 2014 Global Healthcare Conference

CORAL GABLES, Fla., May 29, 2014 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) today announced that the Company will be presenting at the Jefferies 2014 Global Healthcare...
May 16, 2014 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners Announces First Quarter 2014 Financial Results and Provides Corporate Update

CORAL GABLES, Fla., May 16, 2014 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Catalyst) (Nasdaq:CPRX), a specialty pharmaceutical company focused on developing safe and effective...
April 08, 2014 10:30 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners, Inc. Announces Closing of Previously Announced Public Offering

CORAL GABLES, Fla., April 8, 2014 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) today reported that it has closed its previously announced public offering of shares of its...
April 03, 2014 09:00 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners, Inc. Prices Public Offering of Common Stock

CORAL GABLES, Fla., April 3, 2014 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) announced the pricing of its previously announced underwritten public offering of...
April 02, 2014 16:04 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners, Inc. Announces Commencement of Public Offering of Common Stock

CORAL GABLES, Fla., April 2, 2014 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) announced today that it intends to offer shares of its common stock in a public offering....
April 01, 2014 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Announces Completion of Enrollment in Pivotal Phase 3 Trial of Firdapse(TM) in Patients With Lambert-Eaton Myasthenic Syndrome

CORAL GABLES, Fla., April 1, 2014 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX), a specialty pharmaceutical company focused on developing safe and effective, approved...
March 28, 2014 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners Expands Executive Leadership Team to Support the Commercialization of Firdapse(TM)

CORAL GABLES, Fla., March 28, 2014 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX), a specialty pharmaceutical company focused on developing safe and effective, FDA-approved...
March 25, 2014 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners Announces Recommendation of Data Monitoring Committee to Continue Pivotal Phase 3 Clinical Trial for Firdapse(TM)

CORAL GABLES, Fla., March 25, 2014 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX), a specialty pharmaceutical company focused on developing safe and effective approved...
March 19, 2014 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners Announces Fourth Quarter and Year-End 2013 Financial Results and Provides Corporate Update

CORAL GABLES, Fla., March 19, 2014 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Catalyst) (Nasdaq:CPRX), a specialty pharmaceutical company focused on developing safe and effective...
March 06, 2014 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners to Present at the 26th Annual ROTH Conference

CORAL GABLES, Fla., March 6, 2014 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX), today announced that the Company will be presenting at the 26th Annual ROTH Conference, in...